DMRA
Damora Therapeutics, Inc. · Healthcare · Market cap $1.3B
Insiders bought $246K net in the last 90 days ·1 seller, 1 buyer· latest Form 4 filed Sep 28, 2026
Insider Buying
$253K
reported purchases (SEC code P)
Insider Selling
$7K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Sep 28, 2026
Jarrett Jennifer
Damora Therapeutics, Inc. (DMRA) has 3 SEC Form 4 filings (4 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Sep 28, 2026.
Inside the rolling window, 2 insiders at Damora Therapeutics, Inc. reported 1 open-market purchase totaling $253K and 1 open-market sale totaling $7K. Insiders have net bought $246K over the trailing 6 months. The most recent open-market filing is a purchase of 12,500 shares by Director, President and CEO Jarrett Jennifer, dated Sep 25, 2026, worth $253K.
- Industry:Biotechnology
- CEO:Jennifer A. Jarrett
- Employees:7
- HQ:Waltham, MA, US
- IPO:2020-10-29
| Source | |||||||
|---|---|---|---|---|---|---|---|
Jarrett JenniferFirst in 9 months | Director, President and CEO | Purchase | 12,500 | $253K | Sep 28 | -0.4% | SEC ↗ |
Winslow GarrettFirst in 6 months | General Counsel | Sale | 245 | $7K | Jul 8 | -24.9% | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does DMRA have?
Damora Therapeutics, Inc. (DMRA) has 3 SEC Form 4 filings (4 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Sep 28, 2026.
When was the most recent SEC Form 4 filing for DMRA?
The most recent Form 4 filing for DMRA on Tracefour is dated Sep 28, 2026.
What is the net insider flow at DMRA over the last 6 months?
Over the trailing 180 days, insiders at DMRA have net bought $246K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at DMRA in the current window?
Inside the rolling window, insiders at DMRA bought $253K and sold $7K based on SEC Form 4 filings.
Can I get alerts for DMRA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Damora Therapeutics, Inc. (DMRA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Damora Therapeutics, Inc. is in the Healthcare sector.